Headache profiles of patients who were referred to neurology clinics: A subgroup analysis of the Head-MENAA study

被引：0
|
作者：
Genc, Hamit [1 ]
Bolay, Hayrunnisa [2 ]
Baykan, Betul [3 ]
Uluduz, Derya [4 ]
Unal-Cevik, Isin [5 ]
Kissani, Najib [6 ]
Luvsannorov, Otgonbayar [7 ]
Togha, Mansoureh [8 ]
Ozdemir, Asena Ayca [9 ]
Ozge, Aynur [10 ]
机构：
[1] Gaziantep Dr Ersin Arslan Training & Res Hosp, Gaziantep, Turkiye
[2] Gazi Univ, Fac Med, Dept Neurol & Algol, NOROM, Ankara, Turkiye
[3] Istanbul Univ, EMAR Med Ctr, Istanbul Fac Med, Istanbul, Turkiye
[4] Istanbul Univ, Cerrahpasa Fac Med, Istanbul, Turkiye
[5] Hacettepe Univ, Fac Med, Ankara, Turkiye
[6] Cadi Ayyad Univ, Neurosci Res Lab Marrakesh Med Sch, Marrakech, Morocco
[7] Mongolian Natl Univ Med Sci, Ulaanbaatar, Mongolia
[8] Univ Tehran Med Sci, Tehran, Iran
[9] Mersin Univ, Dept Biostat & Med Informat, Mersin, Turkiye
[10] Mersin Univ, Fac Med, Mersin, Turkiye
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
Head-MENAA study; primary headaches; neurology clinics; disease control; emergency service; other services; private office;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-1
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [41] The efficacy and tolerability of a fixed combination of acetylsalicylic acid, paracetamol, and caffeine in patients with severe headache: A post-hoc subgroup analysis from a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study
    Diener, H. C.
    Peil, H.
    Aicher, B.
    CEPHALALGIA, 2011, 31 (14) : 1466 - 1476
  • [42] Oral fingolimod (FTY720) reduces relapse rate in patients previously treated with disease-modifying therapies for multiple sclerosis and in patients who are treatment naive: subgroup analysis of data from a 24-month phase III study (FREEDOMS)
    Hohlfeld, R.
    Calabresi, P. A.
    O'Connor, P.
    Polman, C. H.
    Agoropoulou, C.
    Haering, D.
    Zhang-Auberson, L.
    Kappos, L.
    JOURNAL OF NEUROLOGY, 2010, 257 : S21 - S21
  • [43] Effect of Age on the Efficacy and Safety of Cabozantinib compared to Placebo in Patients with radioiodine-refractory (RAIR) differentiated Thyroid Cancer (DTC) who progressed after VEGFR-directed Therapy: Subgroup Analysis of the Phase 3 COSMIC 311 Study
    Duque-Afonso, J.
    Robinson, B.
    Sherman, S., I
    Krajewska, J.
    Lin, C-C
    Vaisman, F.
    Hoff, A. O.
    Hitre, E.
    Bowles, D. W.
    Hernando, J.
    Banerjee, K.
    Levytskyy, R. M.
    Oliver, J. W.
    Keam, B.
    Capdevila, J.
    Brose, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 155 - 155
  • [44] Pembrolizumab vs placebo for early-stage non.small-cell lung cancer after resection and adjuvant therapy: Subgroup analysis of patients who received adjuvant chemotherapy in the phase 3 PEARLS/KEYNOTE-091 study
    Oselin, Kersti
    Shim, Byoung Yong
    Okada, Morihito
    Bryl, Maciej
    Bonanno, Laura
    Demirag, Guzin
    Colantonio, Ida
    Kimmich, Martin
    Janzic, Urska
    Vansteenkiste, Johan F.
    Caro, Reyes Bernabe
    Scherz, Amina
    Curioni-Fontecedro, Alessandra
    Fruh, Martin
    Wollner, Mira
    Yang, Jing
    Shariati, Nazly
    Marreaud, Sandrine
    Peters, Solange
    O'Brien, Mary Er
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Stone J, Carson A, Duncan R, Roberts R, Warlow C, Hibberd C, Coleman R, Cull R, Murray G, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Smyth R, Walker J, Sharpe M. Who is referred to neurology clinics?-The diagnoses made in 3781 new patients. Clin Neural Neurosurg. 2910;112:747-51
    Landy, Stephen H.
    Kaniecki, Robert G.
    Taylor, Frederick R.
    HEADACHE, 2011, 51 (04): : 628 - 628
  • [46] Efficacy and safety of once weekly dulaglutide monotherapy compared to glimepiride monotherapy in Chinese patients with type 2 diabetes mellitus who were oral antihyperglycemic medication naive: A post hoc analysis of a phase 3 randomized, double-blind study
    Li, Yiming
    Du, Liying
    Hou, Jianing
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [47] Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study)
    Hong, Jin Pyo
    Malek, Akramul Zikri Abd
    Li, Cheng-Ta
    Paik, Jong-Woo
    Sulaiman, Ahmad Hatim
    Madriaga, Gilbert
    Zhuo, Jianmin
    Siggins, Sarah
    Fu, Dong-Jing
    Ju, Po-Chung
    ASIA-PACIFIC PSYCHIATRY, 2023, 15 (04)
  • [48] CLINICAL OUTCOMES OF BARICITINIB 2-MG IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARDS: AN ANALYSIS OF PATIENTS WHO COMPLETED RA-BEACON AND WERE FOLLOWED IN A LONG-TERM EXTENSION STUDY AS WELL AS THE MODIFIED INTENT-TO-TREAT COHORT FROM RA-BEACON
    Wells, A.
    Wu, J.
    Jia, B.
    Quebe, A.
    Griffing, K.
    Helt, C.
    Reis, P. Simoes
    Valenzuela, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 126 - 127
  • [49] Comparison of the safety profiles between insulin mid mixture lispro mix 50 (LM50) and low mixture lispro mix 25 (LM25) as a starter insulin in Chinese patients with type 2 diabetes mellitus: a subgroup analysis of the CLASSIFY study
    Su, Qing
    Hou, Jianing
    Li, Pengfei
    Yang, Wenying
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [50] POST-INFUSION MONITORING COSTS BY SITE OF CARE AMONG PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (LBCL) WHO RECEIVED SECOND-LINE TREATMENT WITH LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSFORM STUDY: A UNITED STATES SUBGROUP ANALYSIS
    McGarvey, N.
    Vaidya, N.
    Gitlin, M.
    Lee, A.
    Ung, B.
    Carattini, T.
    Keating, S. J.
    VALUE IN HEALTH, 2022, 25 (07) : S389 - S389
12345